Cargando…
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
Knowledge on gastrointestinal manifestations in early systemic sclerosis (SSc) is limited. We have investigated gastrointestinal inflammation in SSc at the time of diagnosis using the inflammatory biomarker Fecal calprotectin (F-cal). Consecutive patients with suspected SSc were characterized in rel...
Autores principales: | Hamberg, Viggo, Wallman, Johan K., Mogard, Elisabeth, Lindqvist, Elisabet, Olofsson, Tor, Andréasson, Kristofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073054/ https://www.ncbi.nlm.nih.gov/pubmed/36566433 http://dx.doi.org/10.1007/s00296-022-05264-4 |
Ejemplares similares
-
Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
por: Sagard, Jonas, et al.
Publicado: (2022) -
Elevated levels of faecal calprotectin in primary Sjögren’s syndrome is common and associated with concomitant organic gastrointestinal disease
por: Andréasson, Kristofer, et al.
Publicado: (2016) -
Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016) -
Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016) -
A98 FECAL LEUKOCYTE ESTERASE: AN ALTERNATIVE BIOMARKER TO FECAL CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE
por: Klemm, N K, et al.
Publicado: (2022)